Iovance Biotherapeutics Inc (NASDAQ:IOVA)
| 4.55 BATS BZX Real-Time Price As of 12:46pm ET |  -0.01 / -0.22%Today’s Change | 4.41 Today|||52-Week Range 10.41 | -28.87% Year-to-Date |
Latest IOVA News | Press Releases
| Why Shares of Iovance Biotherapeutics Jumped Monday Sep 18 / MotleyFool.com - Paid Partner Content | Iovance (IOVA) Up Despite FDA's Delayed Decision on Melanoma Drug Sep 15 / Zacks.com - Paid Partner Content |
| Why Iovance Biotherapeutics Stock Rocketed 13% Higher Today Sep 15 / MotleyFool.com - Paid Partner Content | Why Shares of Iovance Biotherapeutics Dropped Thursday Sep 14 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 4.56 |
| Today’s open | 4.68 |
| Day’s range | 4.52 - 4.82 |
| Volume | 113,041 |
| Average volume (3 months) | 6,501,608 |
| Market cap | $1.2B |
Data as of 12:46pm ET, 09/26/2023
Growth & Valuation
| Earnings growth (last year) | -11.42% |
| Earnings growth (this year) | +7.35% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.83 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GERNGeron Corp | +0.02 | +1.15% |
| ARVNArvinas Inc | -0.04 | -0.16% |
| MORFMorphic Holding Inc | -0.92 | -3.97% |
| AUPHAurinia Pharmaceutic... | +0.02 | +0.25% |
Data as of 12:48pm ET, 09/26/2023
Financials
| Next reporting date | November 8, 2023 |
| EPS forecast (this quarter) | -$0.50 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$395.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Carlos, California |
Forecasts
